4.7 Article

Two distinct arginine methyltransferases are required for biogenesis of Sm-class ribonucleoproteins

Journal

JOURNAL OF CELL BIOLOGY
Volume 178, Issue 5, Pages 733-740

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.200702147

Keywords

-

Categories

Funding

  1. NCRR NIH HHS [S10 RR021228, S10 RR017980, S10-RR021228, S10-RR017980] Funding Source: Medline
  2. NICHD NIH HHS [T32 HD007104, T32-HD007104] Funding Source: Medline
  3. NIGMS NIH HHS [R01-GM53034, R01 GM053034] Funding Source: Medline
  4. NINDS NIH HHS [R01 NS041617, R01-NS41617] Funding Source: Medline
  5. Wellcome Trust Funding Source: Medline

Ask authors/readers for more resources

Small nuclear ribonucleoproteins (snRNPs) are core components of the spliceosome. The U1, U2, U4, and U5 snRNPs each contain a common set of seven Sm proteins. Three of these Sm proteins are posttranslationally modified to contain symmetric dimethylarginine (sDMA) residues within their C-terminal tails. However, the precise function of this modification in the snRNP biogenesis pathway is unclear. Several lines of evidence suggests that the methyltransferase protein arginine methyltransferase 5 (PRMT5) is responsible for sDMA modification of Sm proteins. We found that in human cells, PRMT5 and a newly discovered type 11 methyltralferase, PRMT7, are each required for Sm protein sDMA modification. Furthermore, we show that the two enzymes function nonredundantly in Sm protein methylation. Lastly, we provide in vivo evidence demonstrating that Sm protein sDMA modification is required for snRNP biogenesis in human cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available